IRIS
ACAMPA, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.825
EU - Europa 9.015
AS - Asia 4.918
SA - Sud America 844
AF - Africa 289
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 24.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.634
IT - Italia 1.840
RU - Federazione Russa 1.789
CN - Cina 1.626
SG - Singapore 1.549
GB - Regno Unito 1.424
IE - Irlanda 1.043
DE - Germania 871
BR - Brasile 700
SE - Svezia 593
VN - Vietnam 468
FR - Francia 430
HK - Hong Kong 410
UA - Ucraina 376
FI - Finlandia 257
KR - Corea 248
IN - India 165
ZA - Sudafrica 131
BD - Bangladesh 95
CA - Canada 95
NL - Olanda 68
ES - Italia 65
TR - Turchia 59
MX - Messico 54
AR - Argentina 48
CI - Costa d'Avorio 48
IQ - Iraq 45
JP - Giappone 43
NG - Nigeria 42
PL - Polonia 40
AT - Austria 37
BE - Belgio 31
CZ - Repubblica Ceca 30
PK - Pakistan 26
EC - Ecuador 25
GR - Grecia 24
AU - Australia 22
ID - Indonesia 22
IR - Iran 22
CH - Svizzera 20
KE - Kenya 17
VE - Venezuela 15
SA - Arabia Saudita 14
CO - Colombia 13
CL - Cile 12
IL - Israele 12
PH - Filippine 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
LT - Lituania 11
NP - Nepal 10
CR - Costa Rica 9
JM - Giamaica 9
MA - Marocco 9
PY - Paraguay 9
TN - Tunisia 9
MY - Malesia 8
AZ - Azerbaigian 7
DZ - Algeria 7
EU - Europa 7
KG - Kirghizistan 7
PE - Perù 7
RO - Romania 7
BG - Bulgaria 6
BO - Bolivia 6
JO - Giordania 6
LV - Lettonia 6
OM - Oman 6
SI - Slovenia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
EE - Estonia 5
HR - Croazia 5
TH - Thailandia 5
CY - Cipro 4
HU - Ungheria 4
PA - Panama 4
RS - Serbia 4
AL - Albania 3
BB - Barbados 3
BY - Bielorussia 3
HN - Honduras 3
MD - Moldavia 3
MU - Mauritius 3
PS - Palestinian Territory 3
PT - Portogallo 3
SC - Seychelles 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MM - Myanmar 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
Totale 24.892
Salva come PNG Salva come JPEG
Città #
Dallas 1.314
Southend 1.165
Dublin 1.007
Singapore 894
Ashburn 800
Fairfield 800
San Jose 522
Moscow 496
Santa Clara 490
Chandler 478
Milan 475
Beijing 400
Hong Kong 396
Hefei 348
Woodbridge 336
Siena 300
Wilmington 296
Houston 291
Seattle 290
Jacksonville 288
Cambridge 275
Seoul 243
Ann Arbor 234
Council Bluffs 228
New York 178
Princeton 178
Menlo Park 173
Los Angeles 169
Helsinki 142
Rome 140
The Dalles 140
Lauterbourg 127
Ho Chi Minh City 119
Johannesburg 117
Munich 112
Florence 109
Nanjing 109
Hanoi 104
Dong Ket 90
Boardman 88
Dearborn 83
Vimercate 78
São Paulo 71
Buffalo 70
San Diego 64
Shanghai 55
Orem 53
Bengaluru 50
Abidjan 48
London 47
Nanchang 46
Chicago 44
Frankfurt am Main 42
San Mateo 42
Abuja 37
Redondo Beach 35
Tokyo 35
Turku 35
Málaga 34
Columbus 33
San Francisco 33
Toronto 33
Turin 33
Warsaw 33
Brooklyn 31
Lappeenranta 31
Mestre 30
Changsha 29
Pisa 29
Poggiomarino 29
Brussels 28
Montreal 27
Denver 26
Shenyang 26
Nuremberg 25
Guangzhou 23
Paris 23
Amsterdam 22
Da Nang 22
Jiaxing 22
Manchester 22
Tianjin 22
Belo Horizonte 21
Mexico City 21
Brno 20
Figino 20
Rio de Janeiro 20
Washington 20
Livorno 19
Atlanta 18
Boston 18
Brasília 18
Chennai 18
Jinan 18
Lancaster 18
Bologna 17
Vienna 17
Kunming 16
Lograto 16
Stockholm 16
Totale 16.393
Salva come PNG Salva come JPEG
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 423
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 397
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 361
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 361
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 343
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 342
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 317
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 313
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting 305
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 303
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 302
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 296
Systemic thrombolysis for stroke in pregnancy 288
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 284
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 282
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 281
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 280
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 275
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 273
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 271
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 270
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 270
Delineation of the phenotype associated with 7q36.1q36.2 deletion: long QT syndrome, renal hypoplasia and mental retardation 268
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome 265
Cardiac dysautonomia and arterial distensibility in essential hypertensives 257
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 256
Torsades de Pointes in patients with polymyalgia rheumatica 252
Time Course of Corticospinal Excitability and Autonomic Function Interplay during and Following Monopolar tDCS 251
Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation. 251
Neuroimaging and definition of transient ischemic attack 251
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 247
Double ophthalmic arteries arising from the internal carotid artery. A case report of a hidden second ophthalmic artery 241
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 239
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 238
Aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins: response to letter 237
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 232
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 231
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 230
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 230
Connective tissue diseases and cardiac rhythm disorders: an overview 225
Microvascular abnormalities in Rett Syndrome 223
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 220
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 219
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 218
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 217
Stroke warning syndrome: 18 new cases 217
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 216
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 216
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 214
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 213
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 206
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 203
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 202
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 201
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 198
Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation 198
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 194
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 194
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 191
Electromagnetic fields produced by incubators influence heart rate variability in newborns 188
Pharmacogenetics of statins therapy 188
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 188
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 187
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 186
Sympathetic overactivity and plasma leptin levels in Rett syndrome 182
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 179
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 178
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 176
Letter regarding “Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series” 173
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome 171
Sudden death and cardiac arrhythmias in Rett syndrome 168
Long-Term Risk of Arterial Thrombosis after Intracerebral Hemorrhage: MUCH-Italy 167
Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? 166
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 166
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 160
Editorial: Insights in general cardiovascular medicine: 2022 159
Homocysteine and P wave dispersion in patients with heart transplantation 158
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 158
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients 155
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 152
The Impact of Sex and Arterial Stiffness Interactions on the Outcome after an Acute Ischemic Stroke: A Retrospective Cohort Study 152
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 151
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 150
Single-center experience using the 3MAX or 4MAX reperfusion catheter for the treatment of acute ischemic stroke with distal arterial occlusions in patients not eligible for intravenous fibrinolysis 147
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: the MUCH Italy 146
Editorial: New challenges and future perspectives in autonomic neuroscience 144
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 144
Autonomic nervous system alterations in Rett syndrome 144
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 144
Cardiac disease and Rett syndrome 143
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 143
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 142
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 141
null 141
Ischemic stroke after heart transplantation 141
Editorial: Year in review: discussions in general cardiovascular medicine 140
Prevalence of Fabry disease and GLA variants in young patients with acute stroke: the challenge to widen the screening. The Fabry-Stroke Italian Registry 140
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 139
Markers of atrial cardiopathy in severe embolic strokes of undetermined source 137
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 136
Totale 21.668
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.561 114 157 54 130 78 27 56 154 123 128 226 314
2022/20231.837 114 218 247 233 148 339 72 130 150 60 85 41
2023/20242.013 62 27 158 111 87 499 558 47 34 51 118 261
2024/20253.941 105 185 351 319 422 225 178 223 362 181 399 991
2025/20269.690 713 1.308 988 1.069 1.660 359 1.120 311 333 545 368 916
2026/2027169 169 0 0 0 0 0 0 0 0 0 0 0
Totale 25.350